Geron Corp

$1.155
USD
Last updated on --.
24h volume10.09M
24h highest1.1900 USD
24h lowest1.1400 USD
24h Price movement-1.28%

GERN recent prices

24 Hours
-1.28%-$0.015
30 days
-29.39%-$0.485
60 days
-33.43%-$0.585
90 days
-23.86%-$0.365

Key data

Previous close1.1700 USD
Market cap801.90M USD
Volume10.09M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.10000 USD
Net income (FY)-67.31M USD
Revenue (FY)196.12M USD
Last report dateMay 6, 2026

About Geron Corp

PHARMACEUTICAL PREPARATIONS
HeadquartersFOSTER CITY
Employees (FY)258.00
Revenue per employee (FY)760.14K USD
Net income per employee (FY)-260.88K USD
Listed onNasdaq
Official website

GERN conversion tables

GERNGERN
USDUSD
0.5 GERN0.5775 USD
1 GERN1.155 USD
5 GERN5.775 USD
10 GERN11.55 USD
USDUSD
GERNGERN
0.5 USD0.4329 GERN
1 USD0.8658 GERN
5 USD4.329 GERN
10 USD8.658 GERN

FAQ

GERN is trading at $1.155, -1.28% over the last 24 hours. Track live moves on the price chart at the top of this page.
The GERN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GERN is currently trading at $1.155, -1.28% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GERN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GERN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GERN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GERN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Geron Corp's market cap is currently 801.90M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume10.09M
24h highest1.1900 USD
24h lowest1.1400 USD
24h Price movement-1.28%
GERNGERN
USDUSD
Start trade with GERN Perpetual